Please enable JavaScript to continue using this application.

Compare $CLCS vs $TIL | Chartloom

Compare

$CLCS vs $TIL

Cell Source Inc · Instil Bio Inc

CLCS

Cell Source Inc

TIL

Instil Bio Inc

Compare $CLCS vs $TIL

Comparing Cell Source Inc and Instil Bio Inc

CLCSCell Source Inc

TILInstil Bio Inc

CLCSCell Source Inc

Market cap

$37M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-9.1%

52W performance

76.1%

FCF yield

-8.4%

TILInstil Bio Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.2%

52W performance

-67.2%

FCF yield

-73.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLCS

TIL

Detailed metrics comparison

CLCS

Cell Source Inc

TIL

Instil Bio Inc

Market Cap

CLCS$37M

TIL$46M

Enterprise Value

CLCS$48M

TIL$125M

Price

CLCS$0.55

TIL$6.74

P/E Ratio

CLCSN/A

TILN/A

P/S Ratio

CLCS0.00x

TIL0.00x

EV/Sales

CLCS0.00x

TIL0.00x

EV/EBITDA

CLCS0.00x

TIL0.00x

P/B Ratio

CLCSN/A

TIL0.46x

P/FCF Ratio

CLCSN/A

TILN/A

EV/FCF

CLCS-15.29x

TIL-3.73x

PEG Ratio

CLCSN/A

TILN/A

Forward P/E (NTM)

CLCSN/A

TILN/A

Forward P/S (NTM)

CLCSN/A

TILN/A

Revenue (TTM)

CLCS$0

TIL$0

Revenue Growth (YoY)

CLCSN/A

TILN/A

Forward Rev Growth

CLCS0.0%

TIL0.0%

Gross Margin (TTM)

CLCS0.0%

TIL0.0%

Operating Margin (TTM)

CLCS0.0%

TIL0.0%

EBITDA Margin (TTM)

CLCS0.0%

TIL0.0%

Net Margin (TTM)

CLCS0.0%

TIL0.0%

FCF Margin (TTM)

CLCSN/A

TILN/A

Net Income (TTM)

CLCS$-6M

TIL$-30M

FCF (TTM)

CLCS$-3M

TIL$-34M

EPS (TTM)

CLCS-$0.14

TIL-$4.46

ROE (TTM)

CLCS-184198.9%

TIL-2678.0%

ROA (TTM)

CLCS-148238.0%

TIL-1489.0%

ROIC (TTM)

CLCS0.0%

TIL-1529.0%

Cash

CLCS$1K

TIL$6M

Debt

CLCS$11M

TIL$85M

Net Cash/Debt

CLCS$-10M

TIL$-80M

Current Ratio (TTM)

CLCS0.01x

TIL21.67x

Quick Ratio (TTM)

CLCS0.00x

TIL21.19x

Debt/Equity (TTM)

CLCS0.00x

TIL0.79x

Debt/Assets (TTM)

CLCS0.0%

TIL0.0%

Interest Coverage (TTM)

CLCSN/A

TILN/A

Net Debt/EBITDA (TTM)

CLCS0.00x

TIL0.00x

Beta

CLCS23.26

TIL1.90

52W Performance

CLCS76.1%

TIL-67.2%

YTD Performance

CLCS-9.1%

TIL-40.2%

% from 52W High

CLCS-75.8%

TIL-69.3%

% from 52W Low

CLCS199.8%

TIL18.9%

Asset Turnover (TTM)

CLCS0.00x

TIL0.00x

FCF Yield (TTM)

CLCS-8.4%

TIL-73.6%

Earnings Yield (TTM)

CLCS-16.5%

TIL-66.3%

Dividend Yield (TTM)

CLCSN/A

TILN/A

Rule of 40

CLCS0.0

TIL0.0

EV/GP/RG

CLCSN/A

TILN/A

Ticker research

View CLCS research View TIL research

Metric	CLCS Cell Source Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$37M	$46M
Enterprise Value	$48M	$125M
Price	$0.55	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.29x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-30M
FCF (TTM)	$-3M	$-34M
EPS (TTM)	-$0.14	-$4.46
ROE (TTM)	-184198.9%	-2678.0%
ROA (TTM)	-148238.0%	-1489.0%
ROIC (TTM)	0.0%	-1529.0%
Financial Health
Cash	$1K	$6M
Debt	$11M	$85M
Net Cash/Debt	$-10M	$-80M
Current Ratio (TTM)	0.01x	21.67x
Quick Ratio (TTM)	0.00x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	23.26	1.90
52W Performance	76.1%	-67.2%
YTD Performance	-9.1%	-40.2%
% from 52W High	-75.8%	-69.3%
% from 52W Low	199.8%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-73.6%
Earnings Yield (TTM)	-16.5%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLCS research	View TIL research

Valuation

P/S Ratio

CLCS

0.00x

TIL

0.00x

EV/FCF

CLCS

-15.29x

TIL

-3.73x

Growth & revenue

Forward Revenue Growth

CLCS

0.0%

TIL

0.0%

Profitability & performance

Gross Margin

CLCS

0.0%

TIL

0.0%

ROE

TIL

-2678.0%

CLCS

-184198.9%

FCF Yield %

CLCS

-8.4%

TIL

-73.6%

52-Week Performance

CLCS

76.1%

TIL

-67.2%

Detailed metrics comparison

CLCS

Cell Source Inc

TIL

Instil Bio Inc

Market Cap

CLCS$37M

TIL$46M

Enterprise Value

CLCS$48M

TIL$125M

Price

CLCS$0.55

TIL$6.74

P/E Ratio

CLCSN/A

TILN/A

P/S Ratio

CLCS0.00x

TIL0.00x

EV/Sales

CLCS0.00x

TIL0.00x

EV/EBITDA

CLCS0.00x

TIL0.00x

P/B Ratio

CLCSN/A

TIL0.46x

P/FCF Ratio

CLCSN/A

TILN/A

EV/FCF

CLCS-15.29x

TIL-3.73x

PEG Ratio

CLCSN/A

TILN/A

Forward P/E (NTM)

CLCSN/A

TILN/A

Forward P/S (NTM)

CLCSN/A

TILN/A

Revenue (TTM)

CLCS$0

TIL$0

Revenue Growth (YoY)

CLCSN/A

TILN/A

Forward Rev Growth

CLCS0.0%

TIL0.0%

Gross Margin (TTM)

CLCS0.0%

TIL0.0%

Operating Margin (TTM)

CLCS0.0%

TIL0.0%

EBITDA Margin (TTM)

CLCS0.0%

TIL0.0%

Net Margin (TTM)

CLCS0.0%

TIL0.0%

FCF Margin (TTM)

CLCSN/A

TILN/A

Net Income (TTM)

CLCS$-6M

TIL$-30M

FCF (TTM)

CLCS$-3M

TIL$-34M

EPS (TTM)

CLCS-$0.14

TIL-$4.46

ROE (TTM)

CLCS-184198.9%

TIL-2678.0%

ROA (TTM)

CLCS-148238.0%

TIL-1489.0%

ROIC (TTM)

CLCS0.0%

TIL-1529.0%

Cash

CLCS$1K

TIL$6M

Debt

CLCS$11M

TIL$85M

Net Cash/Debt

CLCS$-10M

TIL$-80M

Current Ratio (TTM)

CLCS0.01x

TIL21.67x

Quick Ratio (TTM)

CLCS0.00x

TIL21.19x

Debt/Equity (TTM)

CLCS0.00x

TIL0.79x

Debt/Assets (TTM)

CLCS0.0%

TIL0.0%

Interest Coverage (TTM)

CLCSN/A

TILN/A

Net Debt/EBITDA (TTM)

CLCS0.00x

TIL0.00x

Beta

CLCS23.26

TIL1.90

52W Performance

CLCS76.1%

TIL-67.2%

YTD Performance

CLCS-9.1%

TIL-40.2%

% from 52W High

CLCS-75.8%

TIL-69.3%

% from 52W Low

CLCS199.8%

TIL18.9%

Asset Turnover (TTM)

CLCS0.00x

TIL0.00x

FCF Yield (TTM)

CLCS-8.4%

TIL-73.6%

Earnings Yield (TTM)

CLCS-16.5%

TIL-66.3%

Dividend Yield (TTM)

CLCSN/A

TILN/A

Rule of 40

CLCS0.0

TIL0.0

EV/GP/RG

CLCSN/A

TILN/A

Ticker research

View CLCS research View TIL research

Metric	CLCS Cell Source Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$37M	$46M
Enterprise Value	$48M	$125M
Price	$0.55	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	N/A	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.29x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-30M
FCF (TTM)	$-3M	$-34M
EPS (TTM)	-$0.14	-$4.46
ROE (TTM)	-184198.9%	-2678.0%
ROA (TTM)	-148238.0%	-1489.0%
ROIC (TTM)	0.0%	-1529.0%
Financial Health
Cash	$1K	$6M
Debt	$11M	$85M
Net Cash/Debt	$-10M	$-80M
Current Ratio (TTM)	0.01x	21.67x
Quick Ratio (TTM)	0.00x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	23.26	1.90
52W Performance	76.1%	-67.2%
YTD Performance	-9.1%	-40.2%
% from 52W High	-75.8%	-69.3%
% from 52W Low	199.8%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-73.6%
Earnings Yield (TTM)	-16.5%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLCS research	View TIL research